Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousBone and BonesHematopoietic Stem Cell TransplantationWhole-Body IrradiationTransplantation ConditioningLiver TransplantationAnemia, AplasticLeukemiaTissue DonorsGraft SurvivalKidney TransplantationTransplantation ChimeraHematopoietic Stem CellsHistocompatibility TestingBone Marrow PurgingHistocompatibilityBusulfanImmunosuppressive AgentsBone Marrow DiseasesTransplantation, IsogeneicGraft RejectionStem Cell TransplantationHematologic NeoplasmsHematopoiesisRecurrenceTreatment OutcomeHeart TransplantationTime FactorsCyclophosphamideBone Marrow ExaminationMice, Inbred C57BLLeukemia, Myeloid, AcuteBone RemodelingImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsRadiation ChimeraPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow NeoplasmsLung TransplantationCombined Modality TherapyStem CellsRetrospective StudiesTransplantation ImmunologyCyclosporineAcute DiseaseHepatic Veno-Occlusive DiseaseRemission InductionLymphocyte DepletionGraft vs Host ReactionSurvival AnalysisLeukemia, MyeloidHLA AntigensColony-Forming Units AssayBone DensityOrgan TransplantationLymphoma, Non-HodgkinT-LymphocytesHematologic DiseasesMyelodysplastic SyndromesOpportunistic InfectionsImmunocompromised HostCell DifferentiationLeukocyte TransfusionChimeraNuclear FamilyTransplantationSevere Combined ImmunodeficiencyLymphocyte TransfusionFatal OutcomeBone ResorptionFollow-Up StudiesSurvival RateActuarial AnalysisCells, CulturedFlow CytometryPeripheral Blood Stem Cell TransplantationLeukocyte CountLiving DonorsAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalSpleenPostoperative ComplicationsMultiple MyelomaCell TransplantationMice, Inbred BALB CAntigens, CD34Antilymphocyte SerumCord Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorIslets of Langerhans TransplantationBlood Group IncompatibilityCytomegalovirusInfectionPancytopenia